These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21227624)

  • 1. Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients.
    Saunders J; Nambi V; Kimball KT; Virani SS; Morrisett JD; Lumsden AB; Ballantyne CM; Dong JF;
    J Vasc Surg; 2011 Mar; 53(3):668-75. PubMed ID: 21227624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function.
    Gori AM; Marcucci R; Paniccia R; Giusti B; Fedi S; Antonucci E; Buonamici P; Antoniucci D; Gensini GF; Abbate R
    Thromb Haemost; 2008 Dec; 100(6):1136-45. PubMed ID: 19132241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Aspirin and Clopidogrel Resistance in Patients Undergoing Cardiovascular Surgery: A Single-Center Cross-Sectional Study.
    Özer A; Demirtaş H; Tak S; Koçak B; Yiğiter EN; Oktar GL; Kaya Z
    Turk J Haematol; 2024 May; 41(2):105-112. PubMed ID: 38501691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes.
    Harrison P; Bethel MA; Kennedy I; Dinsdale R; Coleman R; Holman RR
    Platelets; 2019; 30(4):521-529. PubMed ID: 29985735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
    Van der Planken MG; Claeys MJ; Vertessen FJ; Dilling D; Bosmans JM; Berneman ZN; Michiels JJ; Vrints C
    Thromb Res; 2003; 111(3):159-64. PubMed ID: 14678814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease.
    Tirnaksiz E; Pamukcu B; Oflaz H; Nisanci Y
    J Thromb Thrombolysis; 2009 Jan; 27(1):24-8. PubMed ID: 17917708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests.
    Harrison P; Segal H; Silver L; Syed A; Cuthbertson FC; Rothwell PM
    Platelets; 2008 Mar; 19(2):119-24. PubMed ID: 18297549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests.
    Kammerer I; Bach J; Saggau W; Isgro F
    Thorac Cardiovasc Surg; 2011 Oct; 59(7):425-9. PubMed ID: 21437867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
    Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P
    Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
    Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
    Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile and prevalence of aspirin resistance in patients with cardiovascular disease.
    Gum PA; Kottke-Marchant K; Poggio ED; Gurm H; Welsh PA; Brooks L; Sapp SK; Topol EJ
    Am J Cardiol; 2001 Aug; 88(3):230-5. PubMed ID: 11472699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Thromb Haemost; 2010 Aug; 104(2):279-86. PubMed ID: 20508896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
    Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
    Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.